Related Experiment Videos
Zinc in normal and pathological human prostate gland
Ziad M Bataineh1, Ibrahim H Bani Hani, Jamil R Al-Alami
1Department of Anatomy, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan. ziad@just.edu.jo
Saudi Medical Journal
|April 9, 2002
Summary
This study quantifies zinc levels in prostate cells, revealing significant changes in benign prostatic hyperplasia and adenocarcinoma, potentially aiding in diagnosis. Zinc levels in acute prostatitis showed non-significant increases.
Area of Science:
- Urology
- Oncology
- Cell Biology
Background:
- Prostate diseases like benign prostatic hyperplasia (BPH) and adenocarcinoma are significant health concerns.
- Zinc is an essential trace element with known roles in cellular function and disease pathology.
Purpose of the Study:
- To quantitatively detect and analyze zinc distribution within the nuclei and cytoplasm of prostate epithelial cells.
- To compare zinc levels across normal prostate tissue, acute prostatitis, BPH, and prostate adenocarcinoma.
Main Methods:
- Utilized X-ray microanalysis technique for precise zinc detection in prostatic tissue samples.
- Collected and processed samples from patients diagnosed with various prostate conditions over a 2-3 year period.
Main Results:
- Observed significant alterations (both increases and decreases) in nuclear and cytoplasmic zinc levels in benign prostatic hyperplasia and prostate adenocarcinoma.
- Detected a non-significant increase in zinc levels within the nuclei and cytoplasm of epithelial cells in acute prostatitis.
Conclusions:
- The observed zinc level variations may be linked to direct impacts on zinc metabolic pathways or alterations in zinc-bound proteins like metallothionein.
- Quantitative zinc detection in prostate tissues could serve as a valuable diagnostic biomarker for differentiating prostatic pathological conditions and assessing tumor progression.